Chromocell Therapeutics: Entry Into A Material Definitive Agreement, Unregistered Sales Of Equity Securities, Changes In Registrant’s Certifying Accountant, Submission Of Matters To A Vote Of Security Holders, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Pelthos Therapeutics Inc
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***